After a nine-month investigation into direct-to-consumer telehealth platforms launched by Eli Lilly and Pfizer, a group of ...

Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on ...

An Eli Lilly spokesperson told Pharmaceutical Technology: “[The telehealth companies] are deceptively marketing knockoff tirzepatide as safe and effective for ‘cosmetic weight loss ...

Eli Lilly Accused of Defrauding Government in $60 Million Qui Tam Suit - In a qui tam suit alleging that Eli Lilly and Co. (“Eli Lilly”) violated the False Claims Act, a... Menu News & Insights ...

Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by joining as a defendant, stating it wants to end the “entitlement” some ...

Eli Lilly and Co. received a subpoena from the U.S. Department of Justice as part of an investigation into its manufacturing site in Branchburg, New Jersey, the company said in a statement to ...

Eli Lilly and Co and a former employee agreed to settle a lawsuit in which the worker claimed she was terminated after pointing out poor manufacturing practices and data falsification involving ...

The marketing shift comes amid broader Lilly corporate moves as new CEO David Ricks continues to restructure and change up executives. Last week, he appointed a new R&D chief, manufacturing head ...

Nessel announced in January 2022 that she planned to begin an investigation into Eli Lilly’s insulin prices, but acknowledged case law would need to be overturned in order to allow the ...

A European regulatory committee rejected Eli Lilly’s U.S.-approved Alzheimer’s disease treatment over potentially dangerous risks of brain bleeding and swelling. The European Medicines Agency ...

Eli Lilly is spiking higher after the European Commission granted marketing approval for its treatment for severe sepsis, Xigrix, in all 15-member states. The stock is now up 15 cents at $59.72 ...